Pathophysiology of Ischemia Reperfusion Injury and Use of Fingolimod in Cardioprotection
Auteur : Ahmed Naseer
Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is ideal for researchers, cardiovascular scientists, and clinical pharmacologists to further work in this challenging area and apply this knowledge to clinical trials for cardioprotection.
1. Ischemia-Reperfusion Injury2. Myocardial Ischemia3. Myocardial Reperfusion4. Cardioprotection5. Experimental models for Ischemia reperfusion Injury 6. Role of Fingolimod in Cardioprotection
Basic and Translational Researchers, Cardiovascular Scientists and Pharmacologists
- Provides detailed and critical analysis of the latest research in the field from molecular basis to potential clinical relevance
- Examines the effect of fingolimod/sphingosine 1-phosphate in cardioprotection, pointing to future myocardial preventative strategies
Date de parution : 05-2019
Ouvrage de 140 p.
15x22.8 cm